法布雷病的地位和边界
Wei Chu1,2, Min Chen2,3, Xiaoqin Lv4
1Department of Pharmacy, The First People's Hospital of Huzhou, The Directly Affiliated Hospital of Huzhou Teachers College, Huzhou, China.
Orphanet journal of rare diseases
|March 13, 2025
概括
费布里病的治疗方法,包括酶替代和陪伴疗法,面临着局限性. 研究正在探索新的药物和机制,以改善法布里病的管理和控制.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 费布里病源于α-galactosidase A基因的突变,导致有毒脂质积累和器官损伤.
- 目前的治疗方法,如用agalsidase α/β的酶替代疗法 (ERT) 和使用Migalastat的伴侣疗法,存在一些局限性,包括成本,短半衰期,免疫性和有限的适用性.
- 这些局限性要求对法布里病探索新的治疗策略.
研究的目的:
- 审查现有和新兴的治疗法布里病的药物.
- 讨论目前法布里病治疗方法的局限性.
- 突出正在进行的研究新致病机制和辅助疗法.
主要方法:
- 对法布里病的现有和试验药物的文献综述.
- 分析当前的治疗方法,包括酶替代疗法 (ERT) 和陪伴疗法.
- 新兴治疗方法的总结,如下一代ERT,抗体耐药药物和基质还原疗法.
主要成果:
- 阿加尔酶α/β ERT是广泛使用的,但成本昂贵,可以引起免疫反应.
- 密加拉斯塔特护士治疗对特定突变是有效的,但不适用于所有人.
- 一些新的治疗途径正在开发中,以解决当前治疗方法的局限性.
结论:
- 现有的法布里病疗法具有显著的局限性,推动了对创新治疗的需求.
- 对新药和治疗机制的持续研究对于推进法布里病管理至关重要.
- 新治疗方法的开发有望改善疾病控制和患者的治疗结果.
更多相关视频
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
6.1K
10:21Expression, Purification, Crystallization, and Enzyme Assays of Fumarylacetoacetate Hydrolase Domain-Containing Proteins
Published on: June 20, 2019
24.0K
相关概念视频
01:22Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
01:35Pedigree Analysis
83.5K
Overview
83.5K
01:23Cystic Fibrosis: Pathogenesis
174
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
174
03:03Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K